Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVO756 for the Prevention of Migraine in Adults
NCT07616128Phase 2Recruiting
- Sponsor
- Evommune
- Start
- Jul 2026
- Primary completion
- Oct 2027
- Countries
- 4
01
Overview
A Phase 2 trial of EVO756 in migraine, sponsored by Evommune. Started Jul 2026; status: recruiting.
02
Drugs
EVO756
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07616128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616128.